NPs Basic Information

Name
(1r,4r)-1-Methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol
Molecular Formula C10H16O
IUPAC Name*
(1R,4R)-1-methyl-4-prop-1-en-2-ylcyclohex-2-en-1-ol
SMILES
CC(=C)[C@@H]1CC[C@@](C=C1)(C)O
InChI
InChI=1S/C10H16O/c1-8(2)9-4-6-10(3,11)7-5-9/h4,6,9,11H,1,5,7H2,2-3H3/t9-,10-/m0/s1
InChIKey
MKPMHJQMNACGDI-UWVGGRQHSA-N
Synonyms
52154-82-2; 7212-40-0; (1r,4r)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol; (1R,4R)-1-methyl-4-prop-1-en-2-ylcyclohex-2-en-1-ol; (+)-trans-p-Mentha-2,8-dien-1-ol; (1R,4R)-p-Mentha-2,8-dien-1-ol; (1R-TRANS) 1-METHYL-4-(1-METHYLETHENYL)-2-CYCLOHEXENE-1-OL; R1AUQ945JN; 7K859030EU; trans-1-Methyl-4-(1-methylethenyl)-2-cyclohexen-1-ol; (1R,4R)-1-Methyl-4-(prop-1-en-2-yl)cyclohex-2-enol; 4-Isopropenyl-1-methyl-cyclohex-2-en-1-ol, (1R*,4R*), rel-; 2-Cyclohexen-1-ol, 1-methyl-4-(1-methylethenyl)-, (1R,4R)-; 2-Cyclohexen-1-ol, 1-methyl-4-(1-methylethenyl)-, (1R,4R)-rel-; 2-Cyclohexen-1-ol, 1-methyl-4-(1-methylethenyl)-, (1R-trans)-; 2-Cyclohexen-1-ol, 1-methyl-4-(1-methylethenyl)-, trans-; (1R,4R)-1-methyl-4-(1-methylethenyl)-2-cyclohexen-1-ol; rel-(1R,4R)-1-Methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol; cis-p-Mentha-2,8-dien-1-ol; UNII-R1AUQ945JN; (Z)-p-Mentha-2,8-dien-1-ol; UNII-7K859030EU; p-Mentha-2,8-dien-1-alpha-ol; EINECS 230-595-4; FEMA No. 4411, trans-(+-)-; (+-)-trans-p-Mentha-2,8-dien-1-ol; 2,8-P-Menthadien-1-ol, trans-(+-)-; cis-2,8-Menthadien-1-ol; SCHEMBL1114908; trans-1-Methyl-4-(1-methylvinyl)cyclohex-2-en-1-ol; cis-p-Mentha-2,8-diene-1-ol; CHEBI:171978; (1R,4R)-1-methyl-4-(1-methylvinyl)-cyclohex-2-ene-1-ol; DTXSID401301235; p-Menth-2,8-dien-1-ol, cis-; p-Mentha-2,8-dien-1-ol, cis-; ZINC5158342; MFCD08460037; AKOS006288261; Mentha-2,8-dien-1-ol, para, cis-; (1R,4R)-p-Mentha-5,8-diene-1-ol; FEMA NO. 4411, TRANS-(+)-; P-MENTHA-2,8-DIEN-1-.ALPHA.-OL; P-MENTHA-2,8-DIEN-1-OL, TRANS-; 2,8-P-MENTHADIEN-1-OL, TRANS-(+)-; P-MENTHA-2,8-DIEN-1-OL, (1R,4R)-; 2,8-P-MENTHADIEN-1-OL, TRANS-(+/-)-; 4-Isopropenyl-1-methyl-2-cyclohexen-1-ol-, cis; P-MENTHA-2,8-DIEN-1-OL, TRANS-(+/-)-; (1R,4R)-4-Isopropenyl-1-methyl-2-cyclohexen-1-ol; 1-Methyl-4-(1-methylethenyl)-2-cyclohexen-1-ol, cis-; 2-Cyclohexen-1-ol, 1-methyl-4-(1-methylethenyl), cis; (1R,4R)-4-ISOPROPENYL-1-METHYL-CYCLOHEX-2-EN-1-OL, (E)-; (+/-)-(1R,4R)-4-ISOPROPENYL-1-METHYL-CYCLOHEX-2-EN-1-OL, (E)-
CAS 52154-82-2
PubChem CID 111274
ChEMBL ID NA
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Lipids and lipid-like mol
      • Class: Prenol lipids
        • Subclass: Monoterpenoids
          • Direct Parent: Menthane monoterpenoids

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 152.23 ALogp: 2.4
HBD: 1 HBA: 1
Rotatable Bonds: 1 Lipinski's rule of five: Accepted
Polar Surface Area: 20.2 Aromatic Rings: 1
Heavy Atoms: 11 QED Weighted: 0.573

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.301 MDCK Permeability: 0.00002380
Pgp-inhibitor: 0.001 Pgp-substrate: 0.005
Human Intestinal Absorption (HIA): 0.008 20% Bioavailability (F20%): 0.02
30% Bioavailability (F30%): 0.003

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.942 Plasma Protein Binding (PPB): 64.63%
Volume Distribution (VD): 1.435 Fu: 44.07%

ADMET: Metabolism

CYP1A2-inhibitor: 0.139 CYP1A2-substrate: 0.826
CYP2C19-inhibitor: 0.155 CYP2C19-substrate: 0.849
CYP2C9-inhibitor: 0.025 CYP2C9-substrate: 0.544
CYP2D6-inhibitor: 0.013 CYP2D6-substrate: 0.489
CYP3A4-inhibitor: 0.233 CYP3A4-substrate: 0.31

ADMET: Excretion

Clearance (CL): 4.104 Half-life (T1/2): 0.752

ADMET: Toxicity

hERG Blockers: 0.008 Human Hepatotoxicity (H-HT): 0.068
Drug-inuced Liver Injury (DILI): 0.041 AMES Toxicity: 0.008
Rat Oral Acute Toxicity: 0.021 Maximum Recommended Daily Dose: 0.041
Skin Sensitization: 0.061 Carcinogencity: 0.152
Eye Corrosion: 0.927 Eye Irritation: 0.989
Respiratory Toxicity: 0.039
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC000872 0.487 D07QKN 0.220
ENC002264 0.487 D0P0HT 0.188
ENC002860 0.366 D0H1QY 0.184
ENC001835 0.349 D04GJN 0.183
ENC005066 0.276 D0K7LU 0.182
ENC002124 0.276 D0O1UZ 0.179
ENC002051 0.276 D0F1UL 0.177
ENC005497 0.276 D0IL7L 0.176
ENC003085 0.275 D06AEO 0.176
ENC002073 0.273 D0D1SG 0.176
*Note: the compound similarity was calculated by RDKIT.